Longo C - Search Results

1

Early and late complications of endoscopic oesophageal varices sclerotherapy.

Magnano A, Passanisi G, Longo C, Rizzo L, Belluardo N, Russo A. Magnano A, et al. Among authors: longo c. Surg Endosc. 1988;2(4):209-12. doi: 10.1007/BF00705322. Surg Endosc. 1988. PMID: 3266535

2

Prophylactic sclerotherapy in nonalcoholic liver cirrhosis: preliminary results of a prospective controlled randomized trial.

Russo A, Giannone G, Magnano A, Passanisi G, Longo C. Russo A, et al. Among authors: longo c. World J Surg. 1989 Mar-Apr;13(2):149-53. doi: 10.1007/BF01658391. World J Surg. 1989. PMID: 2658361 Clinical Trial.

3

[Isosorbide-5-mononitrate in the prevention of digestive hemorrhage in cirrhosis: randomized study].

Fassio E, Viudez P, Fernández N, Landeira G, Longo C. Fassio E, et al. Among authors: longo c. Acta Gastroenterol Latinoam. 1993;23(4):217-22. Acta Gastroenterol Latinoam. 1993. PMID: 8203183 Clinical Trial. Spanish.

4

Effect of cirrhosis at baseline on the outcome of type 1 autoimmune hepatitis.

Landeira G, Morise S, Fassio E, Ramonet M, Alvarez E, Caglio P, Longo C, Domínguez N. Landeira G, et al. Among authors: longo c. Ann Hepatol. 2012 Jan-Feb;11(1):100-6. Ann Hepatol. 2012. PMID: 22166568 Free article.

5

Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease.

Ruffillo G, Fassio E, Alvarez E, Landeira G, Longo C, Domínguez N, Gualano G. Ruffillo G, et al. Among authors: longo c. J Hepatol. 2011 Jan;54(1):160-3. doi: 10.1016/j.jhep.2010.06.028. Epub 2010 Aug 22. J Hepatol. 2011. PMID: 20934232

6

Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.

Terg R, Fassio E, Guevara M, Cartier M, Longo C, Lucero R, Landeira C, Romero G, Dominguez N, Muñoz A, Levi D, Miguez C, Abecasis R. Terg R, et al. Among authors: longo c. J Hepatol. 2008 May;48(5):774-9. doi: 10.1016/j.jhep.2008.01.024. Epub 2008 Feb 14. J Hepatol. 2008. PMID: 18316137 Clinical Trial.

7

Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins.

Lucero D, Miksztowicz V, Gualano G, Longo C, Landeira G, Álvarez E, Zago V, Brites F, Berg G, Fassio E, Schreier L. Lucero D, et al. Among authors: longo c. Clin Chim Acta. 2017 Oct;473:1-8. doi: 10.1016/j.cca.2017.08.006. Epub 2017 Aug 9. Clin Chim Acta. 2017. PMID: 28802640

8

Risk factors for infection in chronic hepatitis C: a high prevalence of sexual exposure among human immunodeficiency virus-coinfected women.

Fassio E, Landeira G, Longo C, Domínguez N, Alvarez E, Gualano G. Fassio E, et al. Among authors: longo c. Hepatology. 2011 Jul;54(1):379. doi: 10.1002/hep.24224. Epub 2011 Apr 1. Hepatology. 2011. PMID: 21462231 No abstract available.

9

Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies.

Fassio E, Alvarez E, Domínguez N, Landeira G, Longo C. Fassio E, et al. Among authors: longo c. Hepatology. 2004 Oct;40(4):820-6. doi: 10.1002/hep.20410. Hepatology. 2004. PMID: 15382171

10

Effectiveness and safety of original and generic sofosbuvir for the treatment of chronic hepatitis C: A real world study.

Marciano S, Haddad L, Reggiardo MV, Peralta M, Vistarini C, Marino M, Descalzi VI, D'Amico C, Figueroa Escuti S, Gaite LA, Perez Ravier R, Longo C, Borzi SM, Galdame OA, Bessone F, Fainboim HA, Frías S, Cartier M, Gadano AC. Marciano S, et al. Among authors: longo c. J Med Virol. 2018 May;90(5):951-958. doi: 10.1002/jmv.25033. Epub 2018 Feb 15. J Med Virol. 2018. PMID: 29350402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

857 results

Search Page

Filters